{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T23:32:22Z","timestamp":1773963142864,"version":"3.50.1"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T00:00:00Z","timestamp":1562889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100007225","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["104-2320-B-002-063-MY3"],"award-info":[{"award-number":["104-2320-B-002-063-MY3"]}],"id":[{"id":"10.13039\/100007225","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007225","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["106-2923-B-002-001-MY3"],"award-info":[{"award-number":["106-2923-B-002-001-MY3"]}],"id":[{"id":"10.13039\/100007225","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007225","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["107-2320-B-002-061-MY3"],"award-info":[{"award-number":["107-2320-B-002-061-MY3"]}],"id":[{"id":"10.13039\/100007225","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007841","name":"Council of Agriculture","doi-asserted-by":"publisher","award":["107AS-1.2.7-ST-aN"],"award-info":[{"award-number":["107AS-1.2.7-ST-aN"]}],"id":[{"id":"10.13039\/100007841","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In this study, a Food and Drug Administration (FDA)-approved drug with previously unreported antifungal activity was investigated for suitability for use as an anticryptococcal agent. First, we screened a compound library of 1018 FDA-approved drugs against Cryptococcus neoformans. Of 52 drugs possessing anti-Cryptococcus activity, eltrombopag was chosen due to its novel activity. The susceptibility of Cryptococcus against eltrombopag was then studied by determining the minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC), while the synergy of eltrombopag with other drugs was tested by fractional inhibitory concentration index (FICI). Eltrombopag had a limited spectrum of antifungal activity against C. neoformans\/C. gattii species complex (MICs of 0.125\u00a0mg\/l), Candida glabrata (MIC, 0.25\u00a0mg\/l), and Trichophyton rubrum (MIC, 0.5\u00a0mg\/l). Eltrombopag affected cryptococcal virulence factors, including capsule and biofilm formation, melanin production, and growth ability at 37\u00b0C. Further, RNA sequencing and deletion mutant library screening experiments revealed that genes involved in the calcineurin pathway, lipid biosynthesis, membrane component, and transporter genes were associated with eltrombopag. In addition, eltrombopag showed synergism with the calcineurin inhibitor FK506 (FICI &amp;lt; 0.5) against Cryptococcus species. In conclusion, eltrombopag exhibited excellent antifungal activity against Cryptococcus species potentially via a mode of action which interferes with virulence factors and the calcineurin pathway, indicating that eltrombopag might be usefully repurposed as an antifungal agent for treating cryptococcosis.<\/jats:p>","DOI":"10.1093\/mmy\/myz077","type":"journal-article","created":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T11:09:42Z","timestamp":1560856182000},"page":"493-504","source":"Crossref","is-referenced-by-count":16,"title":["Repurposing the thrombopoietin receptor agonist eltrombopag as an anticryptococcal agent"],"prefix":"10.1093","volume":"58","author":[{"given":"Hao-Tai","family":"Ko","sequence":"first","affiliation":[{"name":"Department of Plant Pathology and Microbiology, National Taiwan University, Taipei, 10617 Taiwan"},{"name":"Faculty of Medicine, Medical University of Lublin, Lublin, 20093 Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Hang","family":"Hsu","sequence":"first","affiliation":[{"name":"Department of Plant Pathology and Microbiology, National Taiwan University, Taipei, 10617 Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Yung","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Plant Pathology and Microbiology, National Taiwan University, Taipei, 10617 Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1966-470X","authenticated-orcid":false,"given":"Ying-Lien","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Plant Pathology and Microbiology, National Taiwan University, Taipei, 10617 Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,7,12]]},"reference":[{"key":"2020053120000279000_bib1","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","volume":"17","author":"Rajasingham","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2020053120000279000_bib2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrd.2017.46","article-title":"The antifungal pipeline: a reality check","volume":"16","author":"Perfect","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"2020053120000279000_bib3","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1093\/jac\/dkt221","article-title":"Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal","volume":"68","author":"Loyse","year":"2013","journal-title":"The Journal of antimicrobial chemotherapy"},{"key":"2020053120000279000_bib4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2020053120000279000_bib5","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1080\/21505594.2016.1257457","article-title":"New facets of antifungal therapy","volume":"8","author":"Chang","year":"2017","journal-title":"Virulence"},{"key":"2020053120000279000_bib6","doi-asserted-by":"crossref","first-page":"e00765","DOI":"10.1128\/mBio.00765-13","article-title":"Estrogen receptor antagonists are anti-cryptococcal agents that directly bind EF hand proteins and synergize with fluconazole in vivo","volume":"5","author":"Butts","year":"2014","journal-title":"mBio"},{"key":"2020053120000279000_bib7","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1128\/AAC.00212-12","article-title":"The antidepressant sertraline provides a promising therapeutic option for neurotropic cryptococcal infections","volume":"56","author":"Zhai","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2020053120000279000_bib8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/2040620712442525","article-title":"Eltrombopag, a thrombopoietin- receptor agonist in the treatment of adult chronic immune thrombocytopenia: a review of the efficacy and safety profile","volume":"3","author":"Cheng","year":"2012","journal-title":"Therc Adv Hematol"},{"key":"2020053120000279000_bib9","doi-asserted-by":"crossref","first-page":"e57672","DOI":"10.1371\/journal.pone.0057672","article-title":"Posaconazole exhibits in vitro and in vivo synergistic antifungal activity with caspofungin or FK506 against Candidaalbicans","volume":"8","author":"Chen","year":"2013","journal-title":"PloS One"},{"key":"2020053120000279000_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"2020053120000279000_bib11","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3389\/fmicb.2017.00535","article-title":"The anti-helminthic compound mebendazole has multiple antifungal effects against Cryptococcusneoformans","volume":"8","author":"Joffe","year":"2017","journal-title":"Front Microbiol"},{"key":"2020053120000279000_bib12","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/infdis\/172.4.1153","article-title":"A simplified new assay for assessment of fungal cell damage with the tetrazolium dye, (2,3)-bis-(2-methoxy-4-nitro-5-sulphenyl)-(2H)-tetrazolium-5-carboxanil ide (XTT)","volume":"172","author":"Meshulam","year":"1995","journal-title":"J Infect Dis"},{"key":"2020053120000279000_bib13","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1099\/mic.0.2007\/011049-0","article-title":"Cryptococcus neoformans laccase catalyses melanin synthesis from both D- and L-DOPA","volume":"153","author":"Eisenman","year":"2007","journal-title":"Microbiology"},{"key":"2020053120000279000_bib14","doi-asserted-by":"crossref","first-page":"e01924","DOI":"10.1128\/AAC.01924-17","article-title":"Deletion of ADA2 increases antifungal drug susceptibility and virulence in Candidaglabrata","volume":"62","author":"Yu","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2020053120000279000_bib15","doi-asserted-by":"crossref","first-page":"R14","DOI":"10.1186\/gb-2010-11-2-r14","article-title":"Gene ontology analysis for RNA-seq: accounting for selection bias","volume":"11","author":"Young","year":"2010","journal-title":"Genome Biol"},{"key":"2020053120000279000_bib16","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.cell.2008.07.046","article-title":"Systematic genetic analysis of virulence in the human fungal pathogen Cryptococcusneoformans","volume":"135","author":"Liu","year":"2008","journal-title":"Cell"},{"key":"2020053120000279000_bib17","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1128\/AAC.48.3.985-991.2004","article-title":"Amphotericin B and fluconazole, a potent combination therapy for cryptococcal meningitis","volume":"48","author":"Larsen","year":"2004","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"2020053120000279000_bib18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1086\/588792","article-title":"High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial","volume":"47","author":"Bicanic","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2020053120000279000_bib19","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1128\/AEM.02506-06","article-title":"Cryptococcusneoformans biofilm formation depends on surface support and carbon source and reduces fungal cell susceptibility to heat, cold, and UV light","volume":"73","author":"Martinez","year":"2007","journal-title":"Appl Environ Microbiol"},{"key":"2020053120000279000_bib20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.fgb.2014.09.004","article-title":"Virulence mechanisms and Cryptococcusneoformans pathogenesis","volume":"78","author":"Alspaugh","year":"2015","journal-title":"Fungal Genet Biol"},{"key":"2020053120000279000_bib21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1128\/EC.00351-08","article-title":"Subcellular localization directs signaling specificity of the Cryptococcusneoformans Ras1 protein","volume":"8","author":"Nichols","year":"2009","journal-title":"Eukaryot Cell"},{"key":"2020053120000279000_bib22","doi-asserted-by":"crossref","first-page":"15344","DOI":"10.1016\/S0021-9258(17)36612-7","article-title":"INO2 and INO4 gene products, positive regulators of phospholipid biosynthesis in Saccharomycescerevisiae, form a complex that binds to the INO1 promoter","volume":"269","author":"Ambroziak","year":"1994","journal-title":"J Biol Chem"},{"key":"2020053120000279000_bib23","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1128\/IAI.01514-07","article-title":"Candidaalbicans uses multiple mechanisms to acquire the essential metabolite inositol during infection","volume":"76","author":"Chen","year":"2008","journal-title":"Infect Immun"},{"key":"2020053120000279000_bib24","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1126\/science.1175088","article-title":"An ER-mitochondria tethering complex revealed by a synthetic biology screen","volume":"325","author":"Kornmann","year":"2009","journal-title":"Science"},{"key":"2020053120000279000_bib25","doi-asserted-by":"crossref","first-page":"e23696","DOI":"10.1371\/journal.pone.0023696","article-title":"A genome-wide immunodetection screen in S.cerevisiae uncovers novel genes involved in lysosomal vacuole function and morphology","volume":"6","author":"Ricarte","year":"2011","journal-title":"PloS One"},{"key":"2020053120000279000_bib26","doi-asserted-by":"crossref","first-page":"e01627","DOI":"10.1128\/AAC.01627-18","article-title":"In vitro and in vivo assessment of FK506 analogs as novel antifungal drug candidates","volume":"62","author":"Lee","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2020053120000279000_bib27","first-page":"418","article-title":"Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections","volume":"5","author":"Steinbach","year":"2007","journal-title":"Nature Rev"},{"key":"2020053120000279000_bib28","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1099\/mic.0.28571-0","article-title":"Calcineurin, Mpk1 and Hog1 MAPK pathways independently control fludioxonil antifungal sensitivity in Cryptococcusneoformans","volume":"152","author":"Kojima","year":"2006","journal-title":"Microbiology"},{"key":"2020053120000279000_bib29","first-page":"527","article-title":"Calcineurin governs thermotolerance and virulence of Cryptococcusgattii. G3","author":"Chen","year":"2013"},{"key":"2020053120000279000_bib30","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/emboj\/16.10.2576","article-title":"Calcineurin is required for virulence of Cryptococcusneoformans","volume":"16","author":"Odom","year":"1997","journal-title":"EMBO J"},{"key":"2020053120000279000_bib31","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1128\/JCM.31.12.3305-3309.1993","article-title":"Karyotyping of Cryptococcusneoformans as an epidemiological tool","volume":"31","author":"Perfect","year":"1993","journal-title":"J Clin Microbiol"},{"key":"2020053120000279000_bib32","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/AAC.41.1.156","article-title":"The immunosuppressant FK506 and its nonimmunosuppressive analog L-685,818 are toxic to Cryptococcusneoformans by inhibition of a common target protein","volume":"41","author":"Odom","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"2020053120000279000_bib33","doi-asserted-by":"crossref","first-page":"17258","DOI":"10.1073\/pnas.0402981101","article-title":"A rare genotype of Cryptococcusgattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada)","volume":"101","author":"Kidd","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020053120000279000_bib34","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.fgb.2015.02.009","article-title":"Recognition of seven species in the Cryptococcusgattii\/Cryptococcusneoformans species complex","volume":"78","author":"Hagen","year":"2015","journal-title":"Fungal Genet Biol"},{"key":"2020053120000279000_bib35","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1128\/EC.4.10.1629-1638.2005","article-title":"Comparative gene genealogies indicate that two clonal lineages of Cryptococcusgattii in British Columbia resemble strains from other geographical areas","volume":"4","author":"Kidd","year":"2005","journal-title":"Eukaryot Cell"},{"key":"2020053120000279000_bib36","doi-asserted-by":"crossref","first-page":"7329","DOI":"10.1073\/pnas.0401648101","article-title":"The diploid genome sequence of Candidaalbicans","volume":"101","author":"Jones","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020053120000279000_bib37","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nature08064","article-title":"Evolution of pathogenicity and sexual reproduction in eight Candida genomes","volume":"459","author":"Butler","year":"2009","journal-title":"Nature"},{"key":"2020053120000279000_bib38","doi-asserted-by":"crossref","first-page":"6975","DOI":"10.1128\/AAC.01005-15","article-title":"Rapid development of Candidakrusei echinocandin resistance during caspofungin therapy","volume":"59","author":"Forastiero","year":"2015","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"2020053120000279000_bib39","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nature02579","article-title":"Genome evolution in yeasts","volume":"430","author":"Dujon","year":"2004","journal-title":"Nature"},{"key":"2020053120000279000_bib40","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/nature04332","article-title":"Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillusfumigatus","volume":"438","author":"Nierman","year":"2005","journal-title":"Nature"},{"key":"2020053120000279000_bib41","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ijantimicag.2017.01.029","article-title":"The antibiotic polymyxin B exhibits novel antifungal activity against Fusarium species","volume":"49","author":"Hsu","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"2020053120000279000_bib42","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1128\/AAC.02056-12","article-title":"Comparison of in vitro antifungal activities of efinaconazole and currently available antifungal agents against a variety of pathogenic fungi associated with onychomycosis","volume":"57","author":"Jo Siu","year":"2013","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mmy\/article-pdf\/58\/4\/493\/33196636\/myz077.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/mmy\/article-pdf\/58\/4\/493\/33196636\/myz077.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T01:12:01Z","timestamp":1663722721000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/58\/4\/493\/5531456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,12]]},"references-count":42,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,7,12]]},"published-print":{"date-parts":[[2020,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myz077","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,6]]},"published":{"date-parts":[[2019,7,12]]}}}